| Particulars (Rupees in Crores.) | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
Gross Sales | 108.23 | 85.77 | 87.09 | 83.57 | 79.69 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 108.23 | 85.77 | 87.09 | 83.57 | 79.69 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.12 | 1.62 | 1.67 | 0.58 | 5.51 |
Total Income | 112.35 | 87.39 | 88.76 | 84.15 | 85.2 |
Total Expenditure | 79.94 | 63.73 | 64.35 | 59.47 | 67.44 |
PBIDT | 32.41 | 23.66 | 24.41 | 24.68 | 17.76 |
Interest | 1.9 | 0.63 | 2.56 | 1.53 | 2.26 |
PBDT | 30.51 | 23.03 | 21.85 | 23.15 | 15.5 |
Depreciation | 3.8 | 3.79 | 3.69 | 3.65 | 3.39 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 6.3 | 6.01 | 5.65 | 5.09 | 3.28 |
Deferred Tax | -0.42 | -0.62 | -0.19 | 0.3 | -0.77 |
Reported Profit After Tax | 20.83 | 13.85 | 12.7 | 14.11 | 9.6 |
Minority Interest After NP | 1.11 | -1.19 | -1.16 | -0.74 | -0.37 |
Net Profit after Minority Interest | 19.72 | 15.04 | 13.86 | 14.85 | 9.97 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 19.72 | 15.04 | 13.86 | 14.85 | 9.97 |
EPS (Unit Curr.) | 4.89 | 3.74 | 3.55 | 3.81 | 2.56 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 40.29 | 40.29 | 39 | 39 | 39 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 29.94 | 27.58 | 28.02 | 29.53 | 22.28 |
PBDTM(%) | 28.18 | 26.85 | 25.08 | 27.7 | 19.45 |
PATM(%) | 19.24 | 16.14 | 14.58 | 16.88 | 12.04 |
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
The partnership is seeking to design and manufacture cutting-edge logistics and cargo drones for defence and civilian operations in the country.
EBITDA margins have increased considerably, at 26.2% in Q4 FY25, compared to 15.6% in the corresponding quarter of last year
Paras Defence will launch two models of advanced drone cameras, which sell for ₹20 lakh and ₹40 lakh per piece in the import market.
The project is expected to be operational in 2028.
The projected Optics Park is expected to cost over ₹12,000 Crore over 10 years, depending on land allotment and state government subsidies.
So far this year, this defence player's stock has increased by 42%, compared to a 10% increase in the benchmark Nifty 50.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
